EGFR and non-small cell lung carcinoma: They offer critical support for analyzing gene expression changes linked to EGFR-TKI resistance and tumor microenvironment heterogeneity, paving the way for a deeper understanding of the mechanisms underlying the onset and progression of NSCLC.